Key Takeaway
CJC-1295 vs AOD-9604 comparison. Growth hormone secretagogue (GHRH analog) vs Fat-loss peptide. When to use each and how they differ.
Quick Answer: CJC-1295 vs AOD-9604 compares a two peptides that both affect body composition but through different mechanisms. CJC-1295 stimulates full GH release, providing broad benefits including fat metabolism, lean mass support, sleep, and recovery. AOD-9604 is a GH fragment targeting fat oxidation specifically without other GH effects. CJC-1295 is broader. AOD-9604 is more targeted for fat loss .
Head-to-Head Comparison
| Factor | CJC-1295 | AOD-9604 |
|---|---|---|
| Category | Growth hormone secretagogue (GHRH analog) | Fat-loss peptide |
| Primary role | Extended GH stimulation | Lipolysis stimulation |
| Mechanism | GHRH receptor activation with extended half-life (DAC version) | GH fragment-mediated fat oxidation without growth effects |
| Best for | GH improvement, body composition, sleep, recovery | Stubborn fat reduction, body composition |
| Administration | SC injection daily (often with Ipamorelin) | SC injection daily |
| Evidence | Clinical GH elevation data | Preclinical + limited clinical |
When to Choose CJC-1295
- GH improvement is your primary goal
- You want extended gh stimulation
- GH improvement, body composition, sleep, recovery are your focus areas
When to Choose AOD-9604
- Stubborn fat reduction is your primary goal
- You want lipolysis stimulation
- Stubborn fat reduction, body composition are your focus areas
Can You Use Both?
Yes. CJC-1295 and AOD-9604 work through independent mechanisms and don't interfere with each other. They can be combined when your health goals span both extended gh stimulation and lipolysis stimulation. Your physician can design a protocol that incorporates both compounds with appropriate timing and dosing.
From the FormBlends catalog
AOD-9604
Fat-targeting fragment without growth hormone side effects · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View AOD-9604 →View data table
| Category | Clinical Interest Score | Detail |
|---|---|---|
| BPC-157 | 88 | Tissue repair and gut healing |
| TB-500 | 82 | Injury recovery |
| Sermorelin | 78 | Growth hormone support |
| Ipamorelin | 75 | Anti-aging and recovery |
| GHK-Cu | 70 | Skin and tissue repair |
Frequently Asked Questions
Which has stronger evidence?
CJC-1295 has clinical gh elevation data. AOD-9604 has preclinical + limited clinical. The strength of evidence depends on the specific application you're considering.
Which should I start with?
Start with whichever addresses your most pressing health concern. If you need extended gh stimulation, start with CJC-1295. If you need lipolysis stimulation, start with AOD-9604. A physician can help you prioritize.
Find Your Optimal Protocol
At FormBlends, our physicians evaluate your health goals and recommend the most effective peptide approach, whether single compounds or strategic combinations.
Disclaimer: This article is for informational purposes only and doesn't constitute medical advice. Always consult with a licensed healthcare provider. Individual results may vary.
Ready when you are
AOD-9604
Fat-targeting fragment without growth hormone side effects · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View AOD-9604 →